• Western blot analysis of lysates from 3T3 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-HERC3 antibody (985-1035 aa) (STJ195602)

SKU:
STJ195602

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Probable E3 ubiquitin-protein ligase HERC3 (985-1035 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: HERC3
Gene ID: 8916
Uniprot ID: HERC3_HUMAN
Immunogen Region: 985-1035 aa
Specificity: This antibody detects endogenous levels of HERC3 at Human
Immunogen: Synthesized peptide derived from the human HERC3 at the amino acid range 985-1035
Function E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
Protein Name Probable E3 Ubiquitin-Protein Ligase Herc3
Hect Domain And Rcc1-Like Domain-Containing Protein 3
Hect-Type E3 Ubiquitin Transferase Herc3
Database Links Reactome: R-HSA-983168
Cellular Localisation Cytoplasm
Cytoplasmic Vesicle
Also Found In Vesicular-Like Structures
Alternative Antibody Names Anti-Probable E3 Ubiquitin-Protein Ligase Herc3 antibody
Anti-Hect Domain And Rcc1-Like Domain-Containing Protein 3 antibody
Anti-Hect-Type E3 Ubiquitin Transferase Herc3 antibody
Anti-HERC3 antibody
Anti-KIAA0032 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance